Urgent safety recall issued for weight-loss medicines in South Africa
The South African Health Products Regulatory Authority (SAHPRA) has issued an urgent recall for specific weight-loss medications. The products affected are known as compounded GLP-1 medicines, which are often used for weight management and blood sugar control.
SAHPRA decided to remove these products from shelves due to serious safety concerns. Compounded medicines are created by pharmacists to meet the specific needs of an individual patient when a commercial version of a drug is not available. However, the authority warned that these specific versions do not meet the necessary safety and quality standards required for public use.
Health officials are concerned that these products may pose significant risks to consumers. Because these medicines have not gone through the standard testing and approval processes required for mass-produced pharmaceuticals, their safety and effectiveness cannot be guaranteed.
Patients who are currently using these compounded GLP-1 medicines are advised to stop using them immediately. The regulator recommends that anyone affected should contact their doctor or pharmacist to discuss safer, approved alternatives for their treatment.
SAHPRA continues to monitor the situation closely to ensure that all medical products sold in South Africa are safe for the public. Consumers are encouraged to check their medicine cabinets and consult with healthcare professionals if they have any questions regarding the safety of their current prescriptions.